Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SABER-Bupivacaine in open inguinal hernia repair
NCT00974350Phase 2Completed
- Sponsor
- DURECT Corporation
- Start
- Jan 2007
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of bimatoprost in postoperative pain, sponsored by DURECT Corporation. Started Jan 2007; status: completed.
02
Drugs
bimatoprost
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00974350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974350.